Federal Trade Commission Urged To Probe Shire, Sanofi (France) & Icahn Med School Over A "Conspiracy"

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Two years ago, Shire issued two announcements about its medicine for treating Fabry disease, a rare affliction that causes a buildup of fatty material in the autonomic nervous system, eyes, kidneys and cardiovascular system. On the surface, the announcements – one was about plans to market the drug in the U.S. and the other was about patent litigation – appeared unrelated.

Help employers find you! Check out all the jobs and post your resume.

Back to news